Literature DB >> 980377

Intraocular irritation evaluation of benzalkonium chloride in rabbits.

B Britton, R Hervey, K Kasten, S Gregg, T McDonald.   

Abstract

The purpose of this study was to define the threshold for intraocular irritation of benzalkonium chloride, a preservative used in some formulations which enter the anterior segment of the eye during ocular surgery. Various concentrations of benzalkonium were injected into anterior chambers of albino rabbit eyes. Conjunctivitis, flare, iritis, and corneal changes occurred in a dose response pattern. The threshold of irritation was 0.03%, with highest nonirritating concentration being 0.01%. In other works in this laboratory, threshold of irritation for topical ocular benzalkonium was 0.05%, but the nature of ocular changes was less substantial than those observed intraocularly. Because the threshold for intraocular irritation is less than that topically, the nature of ocular changes was different for two routes, and there is a paucity of clinical data for intraocular benzalkonium chloride, a safety factor of 10 was utilized in setting the highest safe concentration of 0.001% for intraocular use. The preservative efficacy of 0.001% is questionable; therefore, we cannot endorse benzalkonium chloride as a preservative for formulations which will enter the anterior segment of the eye.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 980377

Source DB:  PubMed          Journal:  Ophthalmic Surg        ISSN: 0022-023X


  6 in total

1.  Corneal toxicity secondary to inadvertent use of benzalkonium chloride preserved viscoelastic material in cataract surgery.

Authors:  H Eleftheriadis; M Cheong; S Sandeman; P P Syam; P Brittain; G K Klintworth; A Lloyd; C Liu
Journal:  Br J Ophthalmol       Date:  2002-03       Impact factor: 4.638

Review 2.  Animal models of corneal endothelial dysfunction to facilitate development of novel therapies.

Authors:  Sangwan Park; Brian C Leonard; Vijay Krishna Raghunathan; Soohyun Kim; Jennifer Y Li; Mark J Mannis; Christopher J Murphy; Sara M Thomasy
Journal:  Ann Transl Med       Date:  2021-08

3.  Toxic anterior-segment syndrome (TASS).

Authors:  Servet Cetinkaya; Zeynep Dadaci; Hüsamettin Aksoy; Nursen Oncel Acir; Halil Ibrahim Yener; Ekrem Kadioglu
Journal:  Clin Ophthalmol       Date:  2014-10-09

Review 4.  An overview of biomedical applications of choline geranate (CAGE): a major breakthrough in drug delivery.

Authors:  Mubeshar Riaz; Maida Akhlaq; Sadia Naz; Maliha Uroos
Journal:  RSC Adv       Date:  2022-09-13       Impact factor: 4.036

5.  Development of toxic anterior segment syndrome immediately after uneventful phaco surgery.

Authors:  Jin Seok Choi; Kyung Hwan Shyn
Journal:  Korean J Ophthalmol       Date:  2008-12

6.  A dose-escalation ex vivo study on the effects of intracameral benzalkonium chloride in rabbits.

Authors:  Sergi Segarra; Marta Leiva; Daniel Costa; Natàlia Coyo; Maria Sabés-Alsina; José Ríos; Teresa Peña
Journal:  BMC Vet Res       Date:  2018-02-02       Impact factor: 2.741

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.